Paul D. Thompson MD
Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, ConnecticutDr. Paul Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut in Storrs. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992.
He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors; the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function; and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia.
Dr. Thompson is the co-editor of the book Exercise and Sports Cardiology and of the book Statin-Associated Muscle Symptoms. He is a past president of the American College of Sports Medicine.
Disclosures
- Consultant: Legal consultation on exercise-related cardiac events and statin myopathy
- Research funding: Esperion; Novartis
- Financial interests: Abbott Labs; CVS; Illumina; Novo-Nordisk; GE Healthcare; Johnson & Johnson; Medtronic; OpSens; scPharmaceuticals; Sarepta; Shockwave Medical
Recent Contributions to PracticeUpdate:
- 2024 Top Story in Cardiology: Internal Effects From Environmental Pollution?
- Acute Alcohol Consumption and Arrhythmias in Young Adults
- Associations of "Weekend Warrior" Physical Activity With Incident Disease and Cardiometabolic Health
- Association of Endurance Training With Long-Term Incidences of Bradycardia and Pacemaker Implantation
- Association of Non–HDL-C Levels From Childhood to Adulthood With CVD Events
- Excess Apolipoprotein B and Cardiovascular Risk
- Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure
- Discordance Among apoB, Non–HDL-C, and Triglycerides: Implications for Cardiovascular Prevention
- Relationship Between Physical Activity, Sedentary Time, and Heart Failure Risk in Older Women
- ACC 2024: Recommendations From Dr. Paul Thompson